NEW YORK —
Stocks rose on Monday after a strong gain in retail spending suggested that consumers could be getting more confident about the economy. Bank stocks rose broadly after Citigroup delivered a strong earnings report.
The Dow Jones industrial average was up 87 points at 13,415 in afternoon trading. The Standard & Poor’s 500 index was up nine points at 1,437. The Nasdaq composite index rose 14 points to 3,058.
Companies that rely on consumer spending, like Lowe’s, TJX Cos. and Yum Brands, rose after the government reported that retail sales rose 1.1 percent in the U.S. last month. The Commerce Department also revised August growth up to 1.2 percent, marking the two largest gains since October 2010.
Sales rose in most major categories. Electronics and appliances jumped 4.5 percent with help from the new iPhone. Sales at auto dealers increased 1.3 percent. Building materials and garden supplies, furniture and clothing sales all gained, too.
“The retail sales numbers tell us that the economy in general, and consumer spending in particular, probably did better than most expected in the third quarter,” said Hugh Johnson, chairman and chief investment officer of Johnson Illington Advisors.
Citigroup rose $1.75, or 5 percent, to $36.50 after beating beat Wall Street earnings estimates.
Most other financial stocks followed Citi higher. Bank of America rose 2.6 percent, and JPMorgan Chase rose 1.5 percent. However, Wells Fargo continued to struggle after reporting a record profit on Friday. Analysts warned it might have trouble making money on interest payments for loans. Its stock fell 1.3 percent on Monday, after dropping on Friday, too.
Economic figures from China helped support markets in Europe at the start of a week that could offer greater clarity on the economic fates of Greece and Spain.
China’s inflation rate fell to 1.9 percent in September from 2 percent the month before, reinforcing investor hopes for more stimulus in the world’s second-largest economy.
Good news for two major drugmakers boosted pharmaceutical stocks and pushed the whole health sector to the biggest gains among 10 industry groups in the S&P 500.
Eli Lilly said a potential stomach cancer treatment met goals for improved patient survival. It hasn’t yet submitted the drug, ramucirumab, for government approval.
And Abbott Laboratories said an experimental drug regimen cured 99 percent of patients with hepatitis C. Patients in the trial had genotype 1 hepatitis C, the most common type in the Western world, and the hardest to treat.
Eli Lilly rose $2.01, or 4 percent, to $52.46. Abbott rose $2.65, or 3.8 percent, to $71.91. Other drugmakers also rose. Pfizer, Johnson & Johnson, and Merck were each up more than 1 percent and Bristol-Myers Squibb rose 2.6 percent.
Telecommunications stocks were the only declining industry among the 10 in the S&P 500.
Travel deals website operator Travelzoo Inc. fell again after warning on Friday that its poorly-performing hotel search business will hurt third-quarter results. On Monday, its stock was down 86 cents, or 4.3 percent, to $19.16.
Home health care provider Amedisys Inc. fell $1.35, or 10.1 percent, to $11.98 after saying revenue from health insurer Humana Inc. will shrink.
Investors sold government bonds and drove yields slightly higher. The yield on the 10-year U.S. Treasury note rose to 1.67 percent from 1.66 percent Friday.
The price of crude oil fell a penny to finish at $91.85 on the New York Mercantile Exchange.
Business
Stocks higher after retail sales improve
- Business
-
-
Stocks edge lower as investors wait on Fed
Stocks edged lower in early trading on Wall Street Wednesday as investors waited for word from the Federal Reserve.
-
Investors look for answers on economy from Fed
Worry and speculation have consumed investors since Chairman Ben Bernanke spoke to Congress last month about the Federal Reserve’s drive to keep long-term interest rates at record lows.
-
West Virginia mine safety lab creates disasters to train
Orange flames lick at the roof of the coal mine, heat building and visibility dropping as smoke begins to fill the underground passageway.
-
Dish won’t submit revised bid for Sprint
Satellite TV operator Dish Network Corp. said Tuesday it would not submit a revised bid for Sprint, leaving the path open for the wireless carrier to accept what it already considers a superior offer from Japan’s Softbank.
-
Japan formally OKs new nuke safety requirements
Japan’s nuclear watchdog formally approved a set of new safety requirements for atomic power plants Wednesday, paving the way for the reopening of facilities shut down since the Fukushima disaster in a move critics charge is too hasty.
-
Missouri moves to lift ban on foreign farm owners
Weeks before a Chinese conglomerate agreed to buy Smithfield Foods Inc. in the largest such takeover of a U.S. business, Missouri lawmakers quietly approved legislation removing a ban on foreign ownership of agricultural land.
-
NSA director says plot against Wall Street foiled
The U.S. foiled a plot to bomb the New York Stock Exchange because of the sweeping surveillance programs at the heart of a debate over national security and personal privacy, officials said Tuesday at a rare open hearing on intelligence — a set-piece for supporters of the spying.
-
Waiting for word from Bernanke, stocks move higher
It’s all about the Fed. Still.
-
Chrysler expected to formally refuse Jeep recall
In one of the biggest-ever showdowns between an automaker and the government, Chrysler on Tuesday is expected to file papers explaining its refusal to recall 2.7 million older Jeep SUVs that are at risk of catching fire in rear-end collisions.
-
Sprint sues to stop Dish Clearwire buyout
Sprint is suing to stop Dish Network’s buyout of wireless data network operator Clearwire. The nation’s third-largest cellphone carrier said the proposed deal violates the rights of Sprint and other Clearwire shareholders.
- More Business Headlines
-



